In its latest Market Guide for the space of Enterprise Business Process Analysis, published on 25 April 2016, research and advisory giant Gartner has recognized Cupenya among the vendors representative of the market.
Cupenya and its embedded business process analytics solution is highlighted for its major focus on supporting the strategy-to-execution use-case and its delivery of actionable insights across the organizational hierarchy. Authors of the guide Marc Kerremans and Samantha Searle call Cupenya’s product “very promising”, emphasising the product’s capability to produce predictive and prescriptive analytics.
“This recognition from Gartner is a cornerstone in the life of our young and ambitious company”, says Cupenya CEO Dominik Blattner. “It demonstrates our relentless pursuit of innovation, while at the same time remaining true to the acknowledged needs in the enterprise analytics software space”, Blattner continues.
According to Gartner’s definition, “Enterprise Business Process Analysis (EBPA) is the discipline of business modeling aimed at transforming and improving business performance with an emphasis on cross-viewpoint, cross- function analysis, and strategic and operational decision support. […] EBPA is of interest to business architects, process architects, process analysts, and process owners looking to understand and improve their process-related outcomes”.
“Our dedication to improving process performance for our clients and the delivery of strategy to execution through actionable insights has resulted in concrete benefits in terms of business outcomes and end user satisfaction”, says Blattner.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.